68Ga-P3 PET/CT Imaging in Malignancy
NCT05887687
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
350
Enrollment
OTHER
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
[68Ga]P3
Sponsor
Peking University First Hospital